Dasatinib first-line: Multicentric Italian experience outside clinical trials-Reference-Cited by-同舟云学术

Dasatinib first-line: Multicentric Italian experience outside clinical trials

Published:2016-01 Issue: Volume:40 Page:24-29
ISSN:0145-2126
Container-title:Leukemia Research
language:en
Short-container-title:Leukemia Research

Author:

Breccia Massimo,Stagno Fabio,Luciano Luigiana,Abruzzese Elisabetta,Annunziata Mario,D’Adda Mariella,Maggi Alessandro,Sgherza Nicola,Russo-Rossi Antonella,Pregno Patrizia,Castagnetti Fausto,Iurlo Alessandra,Latagliata Roberto,Cedrone Michele,Di Renzo Nicola,Sorà Federica,Rege-Cambrin Giovanna,La Nasa Giorgio,Scortechini Anna Rita,Greco Giovanna,Franceschini Luca,Sica Simona,Bocchia Monica,Crugnola Monica,Orlandi Esther,Guarini Attilio,Specchia Giorgina,Rosti Gianantonio,Saglio Giuseppe,Alimena Giuliana

Publisher

Elsevier BV

Subject

Cancer Research,Oncology,Hematology

Reference8 articles.

1. Dasatinib;Lindauer;Rec. Results Cancer Res.,2014

2. Dasatinib a guide to its use in chronic myeloid leukemia in the EU;Keating;BioDrugs,2013

3. Early response with dasatinib or imatinib in chronic myeloid leukemia: 3-year follow-up from a randomized phase 3 trial (DASISION);Jabbour;Blood,2014

4. A randomized trial of dasatinib 100mg versus imatinib 400mg in newly diagnosed chronic-phase chronic myeloid leukemia;Radich;Blood,2012

5. S. O’Brien, C. Hedgley, S. Adams, et al. Spirit 2: an NCRI randomised study comparing dasatinib with imatinib in patients with newly diagnosed CML. ASH 2014 abstract 517.

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Neuro-ophthalmic complications of modern anti-cancer drugs;Graefe's Archive for Clinical and Experimental Ophthalmology;2024-02-12

2. Importance of TKI treatment duration in treatment-free remission of chronic myeloid leukemia: results of the D-FREE study;International Journal of Hematology;2023-02-04

3. Contemporary treatment methods of adult patients with BCR/ABL1 positive chronic myeloid leukemia;Vnitřní lékařství;2020-06-01

4. Persistent STAT5-mediated ROS production and involvement of aberrant p53 apoptotic signaling in the resistance of chronic myeloid leukemia to imatinib;International Journal of Molecular Medicine;2017-10-20

5. Reactive follicular hyperplasia on dasatinib treatment for chronic myeloid leukemia;Annals of Hematology;2017-08-19